BEST IN PHYSICS (THERAPY): Tumor Dose Heterogeneity Informed Biological Optimization of Combination Lu-177 PSMA Radiopharmaceutical Therapy and Ir-192 High Dose Rate Prostate Brachytherapy
Focal dose escalation to the dominant intraprostatic lesion (GTV) improves biochemical control but is limited by urethral toxicity. 177Lu-PSMA radiopharmaceutical therapy (RPT) offers a targeted boost, yet its spatial heterogeneity in uptake leaves GTV sub-re...
Proffered Program · Therapy Physics